Home › Funds › PSP Research LLC › VERA
PSP Research LLC position in VERA
VERA THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 7,000 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$300K, representing 0.16% of its reported portfolio and ranking #49 among its reported holdings. PSP Research LLC has disclosed VERA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
How PSP Research LLC's VERA position evolved
PSP Research LLC first disclosed a stake in VERA in Q4 2025 at 9,996 shares (US$506K). Across 3 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 7,000 shares valued at US$300K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 10.00K | $506.20K | New |
| Q1 2026 | 10.00K | $402.30K | Hold |
| Q2 2026 | 7.00K | $300.37K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Avoro Capital Advisors LLC 5.72M sh · $245.61M · Q2 2026
- Deep Track Capital, LP 4.00M sh · $171.64M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 2.89M sh · $124.01M · Q2 2026
- Sofinnova Investments, Inc. 2.79M sh · $119.89M · Q2 2026
- Eversept Partners, LP 2.21M sh · $94.95M · Q2 2026
- Logos Global Management LP 2.20M sh · $94.40M · Q2 2026
- Integral Health Asset Management, LLC 1.75M sh · $75.09M · Q2 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
- Davern Capital Partners, LP 498.83K sh · $21.40M · Q2 2026